SEngine: SEngine plans move to Bothell following $10M round
SEngine, which spun out of Fred Hutchinson Cancer Center in 2015, plans to relocate this fall.
Read full article »
SEngine is a Washington-based biotechnology company that researches and develops precision medicine for the treatment of cancer.
Read more